Skip to main content
Caplight Logo









Throne Biotechnologies Inc.

Throne Biotechnologies Inc.

Private
Paramus, New JerseyHealthcare & Life Scienceshttps://www.thronebio.com/

Last Round

Crowdfunding

Jul 14, 2022

Est. Valuation

$120.04M

Total Funding Raised

$475,006

Company Overview

Throne Biotechnologies Inc. is a biotechnology company that develops a disruptive stem cell technology, Stem Cell Educator therapy, to reverse autoimmune diseases like type 1 diabetes and alopecia areata.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

Stem Cell Educator Therapyex vivo cell therapyautoimmune disease treatmentcell therapyType 1 Diabetes treatmentimmune system resetautologous cell therapyregenerative medicineAlopecia Areata treatmentimmunotherapycord blood stem cellsclinical-stage biotechdialysis-like treatmentRight to Try accessGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Throne Biotechnologies Inc. Comparables

Compare Throne Biotechnologies Inc. with similar companies based on industry and business-model similarity.

Throne Biotechnologies Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NextCell Pharma AB
74%
Sana Biotechnology
64%
Vertex Pharmaceuticals
64%

Throne Biotechnologies Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJul 14, 2022
Convertible DebtDec 31, 2021

Key People

Founding team and executive leadership

Yong Zhao

Founder And CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Monthly visitors increased 43% MoM.

  • Apr 18, 2026

    Monthly visitors increased 46% MoM, reaching 2.7K.

Throne Biotechnologies Inc. Filings

Explore SEC and related filing metadata, where available.

Throne Biotechnologies Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Throne Biotechnologies Inc.'s valuation, stock price, and market status.

Is Throne Biotechnologies Inc. a public or private company?

Throne Biotechnologies Inc. is a private company.

What is the current stock price of Throne Biotechnologies Inc.?

Throne Biotechnologies Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Throne Biotechnologies Inc. worth (valuation)?

Throne Biotechnologies Inc.'s valuation is estimated at $120.0M based on funding round data.

Can I buy Throne Biotechnologies Inc. stock?

Throne Biotechnologies Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Throne Biotechnologies Inc.'s last funding round?

Throne Biotechnologies Inc.'s most recent funding round was Crowdfunding on July 14, 2022.

Who are the main investors in Throne Biotechnologies Inc.?

Investor information for Throne Biotechnologies Inc. is not publicly disclosed.

Will Throne Biotechnologies Inc. IPO soon?

No public IPO plans have been announced for Throne Biotechnologies Inc..

How can I track Throne Biotechnologies Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Throne Biotechnologies Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParamus, New Jersey
Employee Range6
Year Founded2011
Last FundingJul 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?